ANNX

ANNX

USD

Annexon Inc. Common Stock

$2.520-0.140 (-5.263%)

リアルタイム価格

Healthcare
バイオテクノロジー
米国

価格チャート

Loading Chart...

主要指標

市場指標
企業ファンダメンタルズ
取引統計

市場指標

始値

$2.660

高値

$2.670

安値

$2.510

出来高

1.85M

企業ファンダメンタルズ

時価総額

276.5M

業種

バイオテクノロジー

United States

取引統計

平均出来高

1.80M

取引所

NMS

通貨

USD

52週レンジ

安値 $1.285現在値 $2.520高値 $7.85

関連ニュース

GlobeNewswire

Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting

First Oral Presentation of the Tanruprubart Real-World Evidence (RWE) Study by International Guillain-Barré Syndrome Outcomes Study (IGOS) Researchers Highlights Benefits over Current Standard of Care in Matched Patient

もっと見る
Annexon Showcases Tanruprubart Data Demonstrating Improved Clinical Outcomes in Guillain-Barré Syndrome (GBS) at 2025 Peripheral Nerve Society (PNS) Annual Meeting
GlobeNewswire

Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)

BRISBANE, Calif., May 16, 2025 (GLOBE NEWSWIRE) -- Annexon, Inc. (NASDAQ:ANNX), a biopharmaceutical company advancing a late-stage clinical platform of novel therapies for people living with devastating classical

もっと見る
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
Analyst Upgrades

HC Wainwright & Co. Maintains Buy on Annexon, Lowers Price Target to $14

HC Wainwright & Co. analyst Andrew Fein maintains Annexon with a Buy and lowers the price target from $20 to $14.

もっと見る
HC Wainwright & Co. Maintains Buy on Annexon, Lowers Price Target to $14